OOIR: Observatory of International Research

Papers

(The TQCC of Allergy and Asthma Proceedings is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Impact of steroids on the immune profiles of children with asthma living in the inner-city	85
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	29
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	28
Venom allergen immunotherapy	27
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	24
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis	21
Future directions in allergen immunotherapy	21
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	19
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	19
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	19
Operationalizing shared decision making in clinical practice	19
Breathing through the night: A meta-analysis of childhood asthma and obstructive sleep apnea in sleep-disordered contexts	19
For the Patient	17
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	17
For the Patient	17
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes	16
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy	15
Evaluation and management of chronic cough in adults	15
Recurrent full-body rash following chemotherapy initiation in a multiple myeloma patient	14
TEV/FEV₃ as a coherent metric of small airway dysfunction in childhood asthma	14
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps	14
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	14
Optimizing diagnostic approaches for allergic bronchopulmonary aspergillosis: Comparative analysis of IgG/IgE ELISA and serum precipitins assays	14
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	13
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy	13

Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs	12
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome	12
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department	12
For the Patient	12
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics	12
Effects of mechanical washing and drying on the removal of pet allergens	12
Utility of basophil activation tests in the diagnosis of cross-intolerance to nonsteroidal anti-inflammatory drug reactions	12
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	12
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment	11
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii	11
A tribute to allergy and immunology fellowship training program directors and to the fellows they train	11
Artificial intelligence and allergy: Shaping the future of diagnosis and therapy	11
Navigating the management complexity in long-term asymptomatic immunodeficiency	11
For the patient	11
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?	11
Diagnostic utility of basophil CD203c expression in β-lactam allergy	11
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities	11
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab	10
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention	10
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii	10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination	10
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy	10
Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze	10
Benralizumab in the management of rare primary eosinophilic lung diseases	10
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	10
Metal implant allergy: A retrospective cohort analysis at a university allergy practice	10
The long COVID syndrome: A conundrum for the allergist/immunologist	10
Evaluation of atopic diseases in patients with allergic contact dermatitis	9
Cost-effectiveness of school integrated pest management and air filtration in students with asthma	9
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	9
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study	9
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema	9
Primary Immunodeficiency: Specific antibody deficiency with normal IgG	9
Overview of secondary immunodeficiency	8
The association of timothy grass allergy and cat ownership on cat sensitization	8
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization	8
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	8
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis	8
Hematopoietic stem cell transplantation for primary immunodeficiency	8
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	8
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	8
Curcumin does not significantly affect immediate skin tests	8
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	8
Rethinking the management of hereditary angioedema	8
Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review	8
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab	8
For the Patient	8
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	8
Assessing cross-reactivity in allergen immunotherapy	7
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	7

2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	7
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic	7
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis	7
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience	7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	7
Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations	7
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough	7
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers	7
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	7
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	7
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study	7
Immunodeficiency: Burden of Illness	7
For the patient	6
Winged hymenoptera: Discordance between In vitro and In vivo sensitization	6
Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis	6
Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis	6
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors	6
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria	6
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida	6
A masquerade of recurrent anaphylaxis	6
Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal	6
Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience	6
Expanding horizons of omalizumab: New frontiers in asthma and beyond	6
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema	6
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	6
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma	6
Genetically-determined defects of T cell development	6
Peanut allergy in an adult following cardiac transplant from a non-atopic donor	6
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)	6
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis	6
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis	6
Cat allergy in children and the effect of the COVID-19 pandemic	6
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy	6
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease	6